Seelos Therapeutics Investor Relations Material
Latest events
Q2 2024
14 Aug, 2024
Q1 2024
14 May, 2024
Access the full event backlog
Slides, Transcripts, and Reports from 13,000 public companies
Latest reports from Seelos Therapeutics Inc
Access all reports
Seelos Therapeutics, Inc. is a biotechnology company focused on developing treatments for central nervous system disorders and other rare diseases. The company’s research and development efforts target neurological, psychiatric, and neurodegenerative conditions. The company is headquartered in New York, New York, and its shares are listed on the OTCQB.
Latest articles
)
Where to? The Story of Uber
Uber's journey from rule-breaking disruptor to disciplined dual-app giant, now shaping the future of mobility, delivery, and autonomy.
5 Sep 2025
)
The Dilemma That Brought Down Kodak
Kodak helped invent digital photography but failed to embrace it. How the innovator's dilemma turned an icon into its own most famous casualty.
21 Aug 2025
)
Maziar Mike Doustdar: Novo Nordisk's New CEO
A portrait of the pharmaceutical giant's new CEO, who assumes the position at a critical time for the company in its competition with Eli Lilly.
12 Aug 2025
Ticker symbol
SEEL.Q
Country
🇺🇸 United States